| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14,6 M € | +17.1% | 12,5 M € | +17.4% | 10,6 M € | -2.8% | 10,9 M € | +7.2% | 10,2 M € | +21.9% | 8,3 M € | -0.7% | 8,4 M € | -4.7% | 8,8 M € | +4.0% | 8,5 M € | +1.5% | 8,4 M € | +0.6% | 8,3 M € | +6.1% | 7,8 M € | +4.9% | 7,5 M € | -0.8% | 7,5 M € | +5.6% | 7,1 M € | +8.3% | 6,6 M € | -4.0% | 6,9 M € | +12.3% | 6,1 M € | +13.9% | 5,4 M € | -7.9% | 5,8 M € | |
| EBITDA | 3,5 M € | +6800.1% | -52,7 k € | +79.4% | -255,8 k € | -150.4% | 507,6 k € | -47.7% | 970,9 k € | +12.3% | 864,6 k € | +9.8% | 787,3 k € | -13.8% | 913,0 k € | +40.3% | 650,7 k € | -12.1% | 740,6 k € | +3.7% | 714,5 k € | +28.1% | 557,6 k € | +7.9% | 517,0 k € | -27.0% | 708,0 k € | +103.7% | 347,6 k € | -8.4% | 379,5 k € | -51.1% | 775,7 k € | +31.0% | 592,3 k € | +171.9% | 217,9 k € | -43.9% | 388,2 k € | |
| Operating profit | 3,6 M € | +4895.8% | -74,8 k € | +75.9% | -310,5 k € | -169.9% | 444,4 k € | -50.7% | 901,6 k € | +12.1% | 804,2 k € | +11.9% | 718,6 k € | -3.9% | 748,1 k € | +123.9% | 334,1 k € | -42.5% | 581,6 k € | -10.2% | 648,0 k € | +40.9% | 459,9 k € | +77.4% | 259,2 k € | -53.2% | 553,8 k € | +131.0% | 239,8 k € | -21.0% | 303,5 k € | -58.3% | 727,4 k € | +32.2% | 550,4 k € | +189.3% | 190,3 k € | -47.6% | 363,3 k € | |
| Profit/loss | 2,6 M € | +2759.4% | -99,2 k € | +67.0% | -300,4 k € | -207.9% | 278,4 k € | -56.8% | 644,8 k € | +10.1% | 585,6 k € | +20.2% | 487,0 k € | +21.0% | 402,6 k € | +130.1% | 175,0 k € | -49.0% | 343,4 k € | -12.0% | 390,3 k € | +40.6% | 277,6 k € | +598.7% | 39,7 k € | -87.0% | 305,0 k € | +176.8% | 110,2 k € | -34.2% | 167,3 k € | -63.8% | 462,5 k € | +32.1% | 350,2 k € | +1484.0% | 22,1 k € | -87.4% | 174,9 k € | |
| Equity | 1,3 M € | -50.8% | 2,7 M € | -3.6% | 2,8 M € | -9.7% | 3,1 M € | +9.9% | 2,8 M € | +29.9% | 2,2 M € | -18.0% | 2,6 M € | +22.7% | 2,1 M € | +23.1% | 1,7 M € | +11.2% | 1,6 M € | -6.4% | 1,7 M € | +7.3% | 1,6 M € | +21.6% | 1,3 M € | +3.2% | 1,2 M € | +15.5% | 1,1 M € | +0.6% | 1,1 M € | +0.8% | 1,1 M € | +0.2% | 1,1 M € | +0.0% | 1,1 M € | -15.5% | 1,3 M € | |
| Total assets | 9,5 M € | +100.0% | 4,7 M € | +1.9% | 4,6 M € | +0.1% | 4,6 M € | +2.3% | 4,5 M € | -1.0% | 4,6 M € | +7.1% | 4,3 M € | +15.2% | 3,7 M € | -8.2% | 4,0 M € | -8.3% | 4,4 M € | +16.4% | 3,8 M € | +4.5% | 3,6 M € | +11.0% | 3,3 M € | -16.5% | 3,9 M € | +6.9% | 3,7 M € | +0.5% | 3,6 M € | -6.4% | 3,9 M € | +3.2% | 3,8 M € | +11.1% | 3,4 M € | -28.7% | 4,8 M € | |
| Cash | 39,4 k € | -96.6% | 1,2 M € | +332.8% | 268,9 k € | -41.7% | 461,3 k € | -26.8% | 629,9 k € | +21.6% | 518,1 k € | +18.9% | 435,8 k € | -21.7% | 556,9 k € | +46.2% | 380,8 k € | +15.7% | 329,2 k € | -61.9% | 864,1 k € | +13.0% | 764,5 k € | +14.7% | 666,3 k € | -7.4% | 719,5 k € | +20.6% | 596,7 k € | +94.5% | 306,7 k € | -18.9% | 378,4 k € | -2.9% | 389,6 k € | +53.2% | 254,3 k € | -17.4% | 308,0 k € | |
| Debts | 8,0 M € | +331.9% | 1,9 M € | +10.1% | 1,7 M € | +12.2% | 1,5 M € | -12.4% | 1,7 M € | -29.0% | 2,4 M € | +54.5% | 1,6 M € | +7.5% | 1,4 M € | -30.2% | 2,1 M € | -18.6% | 2,6 M € | +43.1% | 1,8 M € | +6.6% | 1,7 M € | -7.3% | 1,8 M € | -28.2% | 2,5 M € | +3.9% | 2,4 M € | -1.0% | 2,4 M € | -8.9% | 2,7 M € | +4.9% | 2,6 M € | +17.8% | 2,2 M € | -35.7% | 3,4 M € | |
| Staff | 17,6 | 23,9 | 24,3 | 23,4 | 18,8 | 15,3 | 16,7 | 20,9 | 21,9 | 21,4 | 21,4 | 21,9 | 22,1 | 21,8 | 20,3 | 19,9 | 18,8 | 20 | 20,1 | 19,3 | ||||||||||||||||||||
Public limited company · Gent · incorporated on 23/09/1970 · 17,6 ETP
Public limited company profitable but thinly capitalised. Cash position declining (-96.6%).
Solid counterparty for a standard engagement.
Ceres Pharmaceuticals is a Public limited company incorporated in 1970. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Gent. It employs on average 17,6 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette